摘要
Abstract
Objective: To investigate the clinical ef icacy of antiplatelet drugs on children with nephrotic syndrome. Methods: in 2011 April to 2013 April 86 cases of nephrotic syndrome in children, were randomly divided into experimental group and control group. The test group with smal dose aspirin antiplatelet drugs on the basis of conventional therapy, the control group conventional treatment. Results:the treatment group's recent remission rate, urine protein negative than those in the control group, the incidence rate of adverse reaction was lower than the control group. Conclusion: platelet activation and the relationship between hypercoagulability in nephrotic, is one of the factors af ecting the prognosis, based on routine treatment in children with nephrotic syndrome drug adding less dose antiplatelet activity can improve the clinical ef icacy. The use of smal dose of antiplatelet drug, has a good ef ect on reducing proteinuria.关键词
抗血小板活性药物/儿童肾病综合征Key words
The antiplatelet drugs/Children with nephrotic syndrome
